Interventional glaucoma: Redefining the optometrist’s role in modern glaucoma management | Optometry Times - Clinical News

Published on November 6, 2025
A shift toward minimally invasive, evidence-based interventions is redefining standards of care.
Continue reading on website
Other news

Tarsus Achieves Strong Third Quarter Financial Results, Driven by Growing Xdemvy Prescriptions

November 6, 2025
IRVINE, Calif.—Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS) a biopharmaceutical company focused on the development and commercialization of therapeutic eyecare treatments, has announced financial results for the third quarter ended September 30, 2025. Net product sales for the quarter were reported at $118.7 million, compared with $48.1 million for the same period in 2024, driven by more than 103,0

National Database Study Supports AMD Protective Effect in GLP-1 Drug Users

November 6, 2025
A new analysis published in Ophthalmology Retina using the TriNetX national cohort found that patients prescribed GLP-1 receptor agonists had a lower risk of developing either dry or wet AMD. However, it did not affect the rate of conversion to neovascular AMD among patients with the non-neovascular form at baseline. Photo: Tanuj P. Banker, MD. Click image to enlarge. Glucag